FDA
approval
· 2024-05-01
FDA Approved: TALICIA — Supplemental Application (RedHill Biopharma Ltd)
Summary
The FDA approved a supplemental application for TALICIA, a fixed-dose combination of omeprazole magnesium, amoxicillin, and rifabutin developed by RedHill Bioph…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TALICIA (OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN)